Publications: Prof. Dr. med. univ. G. Schett
- Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial. Rheumatol Int. 2023;43(4): 695-703
- Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition. Arthritis Rheumatol. 2023;75(4): 517-532
- Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Ann Rheum Dis. 2023;82(4): 483-495
- Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography. Rheumatology (Oxford). 2023;62(2): 841-849
- Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. RMD Open. 2023;9(1):
- Concepts of Entheseal Pain. Arthritis Rheumatol. 2023;75(4): 493-498
- Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based study. Rheumatol Int. 2023;43(3): 495-502
- Clinical Images: Increased bone metabolism in secondary hyperparathyroidism. Arthritis Rheumatol. 2023;75(6):
- Chronic Systemic Infection of Mice with Leishmania infantum Leads to Increased Bone Mass. J Bone Miner Res. 2023;38(1): 86-102
- Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey. Rheumatol Int. 2023;43(4): 713-719
- Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT. Eur J Nucl Med Mol Imaging. 2023;50(6): 1629-1635
- An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study. Diagnostics (Basel). 2023;13(1):
- Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance. Rheumatology (Oxford). 2023;62(2): e21-e23
- Successful Generation of CD19 Chimeric Antigen Receptor T Cells from Patients with Advanced Systemic Lupus Erythematosus. Transplant Cell Ther. 2023;29(1): 27-33
- Cellular plasticity and myeloid inflammation in the adult brain are independent of the transcriptional modulator DREAM. Neurosci Lett. 2023;796():
- Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy. Blood Adv. 2023;7(10): 2066-2069
- Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis. Rheumatology (Oxford). 2023;62(10): 3448-3458
- Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ. 2023;30(4): 861-875
- Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. ACR Open Rheumatol. 2023;5(4): 227-240
- Analysis of Hand Joint Space Morphology in Women and Men with Hereditary Hemochromatosis. Calcif Tissue Int. 2023;112(4): 440-451
- VEXAS syndrome mimicking lupus-like disease. Rheumatology (Oxford). 2023;62(9): e271-e272
- Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. RMD Open. 2023;9(1):
- Multispectral optoacoustic tomography of the human intestine - temporal precision and the influence of postprandial gastrointestinal blood flow. Photoacoustics. 2023;30():
- EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Ann Rheum Dis. 2023;82(9): 1162-1170
- Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study. Rheumatol Int. 2023;43(10): 1905-1911
- Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study. Rheumatology (Oxford). 2023;():
- Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis. Ther Adv Musculoskelet Dis. 2023;15():
- Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes. J Exp Med. 2023;220(6):
- Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial. J Clin Med. 2023;12(11):
- Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. J Rheumatol. 2023;50(Suppl 2): 61-65
- Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis. Z Rheumatol. 2023;():
- Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. Rheumatology (Oxford). 2023;():
- Contrast-Enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Tract. Adv Sci (Weinh). 2023;10(23):
- IgA2 immune complexes selectively promote inflammation by human CD103+ dendritic cells. Front Immunol. 2023;14():
- Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet's Syndrome and Psoriatic Arthritis. Int J Mol Sci. 2023;24(10):
- Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus. Rheumatology (Oxford). 2023;62(11): 3619-3626
- Performance of serum biomarkers reflective of different pathogenic processes in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023;():
- Magnetic resonance imaging techniques for the quantitative analysis of skeletal muscle: State of the art. J Orthop Translat. 2023;42(): 57-72
- Amelioration of Fibrotic Remodeling of Human 3-Dimensional Full-Thickness Skin by Transglutamase 2 Inhibition. Arthritis Rheumatol. 2023;75(9): 1619-1627
- Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease. J Autoimmun. 2023;139():
- Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases. Radiat Oncol. 2023;18(1):
- Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1. Immunity. 2023;56(5): 1046-1063.e7
- Neutrophil Extracellular Traps Drive Dacryolithiasis. Cells. 2023;12(14):
- Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T-cells after failure of several B cell depleting antibodies. Rheumatology (Oxford). 2023;():
- Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy. Mol Ther Methods Clin Dev. 2023;31():
- Suppression of neutrophils by sodium exacerbates oxidative stress and arthritis. Front Immunol. 2023;14():
- Author Correction: DeepNAPSI multi-reader nail psoriasis prediction using deep learning. Sci Rep. 2023;13(1):
- DeepNAPSI multi-reader nail psoriasis prediction using deep learning. Sci Rep. 2023;13(1):
- Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension. Semin Arthritis Rheum. 2023;63():
- Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey. Rheumatol Int. 2023;43(10): 1925-1934
- CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet. 2023;401(10379): 815-818
- CAR T-cell therapy in autoimmune diseases. Lancet. 2023;402(10416): 2034-2044
- High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic γδ T cell IL-17 production. Cell Rep. 2023;42(7):
- Imaging in inflammatory arthritis: progress towards precision medicine. Nat Rev Rheumatol. 2023;19(10): 650-665
- The bone marrow side of axial spondyloarthritis. Nat Rev Rheumatol. 2023;19(8): 519-532
- Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. Rheumatology (Oxford). 2023;():
- Misdiagnosis of polymyositis in a young female patient with occult limb-girdle muscular dystrophy. Rheumatol Adv Pract. 2023;7(2):
- Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial. Arthritis Rheumatol. 2023;75(11): 1923-1934
- Alcohol-sourced acetate impairs T cell function by promoting cortactin acetylation. iScience. 2023;26(7):
- Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine. Infection. 2023;51(6): 1657-1667
- Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. Ann Rheum Dis. 2023;82(8): 1117-1120
- Rationale, current state and opportunities in combining biologic disease modifying antirheumatic drugs in rheumatoid and psoriatic arthritis. Joint Bone Spine. 2023;90(5):
- Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. Arthritis Res Ther. 2023;25(1):
- Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. Arthritis Res Ther. 2023;25(1):
- Opportunistic screening with CT: comparison of phantomless BMD calibration methods. J Bone Miner Res. 2023;():
- ["Rheuma (be-)greifen"- A multimodal teaching concept to improve rheumatology education for medical students]. Z Rheumatol. 2023;():
- Addendum: Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes. J Exp Med. 2023;220(7):
- A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine. 2023;48():
- Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis Model. Arthritis Rheumatol. 2023;75(7): 1152-1165
- Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world setting. Rheumatology (Oxford). 2023;62(4): 1476-1484
- Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells. Arthritis Rheumatol. 2023;75(5): 768-781
- Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort. Arthritis Rheumatol. 2022;74(5): 783-790
- Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer. J Pathol. 2022;256(4): 455-467
- At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionals. BMC Health Serv Res. 2022;22(1):
- Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study. BMC Health Serv Res. 2022;22(1):
- Potent anti-inflammatory activity of the lectin-like domain of TNF in joints. Front Immunol. 2022;13():
- Review and Analysis of German Mobile Apps for Inflammatory Bowel Disease Management Using the Mobile Application Rating Scale: Systematic Search in App Stores and Content Analysis. JMIR Mhealth Uhealth. 2022;10(5):
- Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy. Rheumatol Int. 2022;42(12): 2167-2176
- Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease. Ann Rheum Dis. 2022;81(10): 1400-8
- Interspecies Single-Cell RNA-Seq Analysis Reveals the Novel Trajectory of Osteoclast Differentiation and Therapeutic Targets. JBMR Plus. 2022;6(7):
- Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity. Int J Mol Sci. 2022;23(3):
- Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases. RMD Open. 2022;8(2):
- Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arthritis. Arthritis Res Ther. 2022;24(1):
- Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (September, 10.1038/s41591-022-02017-5, 2022) Nat Med. 2022;():
- Angiotensin AT2 Receptor Stimulation Alleviates Collagen-Induced Arthritis by Upregulation of Regulatory T Cell Numbers. Front Immunol. 2022;13():
- Impaired Mitochondrial Transcription Factor A Expression Promotes Mitochondrial Damage to Drive Fibroblast Activation and Fibrosis in Systemic Sclerosis. Arthritis Rheumatol. 2022;74(5): 871-881
- Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease. Ann Rheum Dis. 2022;81(7): 1023-1027
- IgA anti-citrullinated protein antibodies are associated with flares during DMARD tapering in rheumatoid arthritis. Rheumatology (Oxford). 2022;61(5): 2124-2131
- Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings. Clin Rev Allergy Immunol. 2022;63(2): 138-151
- Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE. Rheumatology (Oxford). 2022;61(5): 1867-1876
- Response to: "Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab- treated patients: Comment on article of Simon et al". Arthritis Rheumatol. 2022;74(5): 909-910
- Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab. Clin Exp Rheumatol. 2022;40(4): 854-855
- EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2022;81(1): 20-33
- Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA. Ann Rheum Dis. 2022;81(3): 445-447
- Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations. Rheumatology (Oxford). 2022;61(8): 3289-3298
- Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy. Rheumatology (Oxford). 2022;61(7): 2999-3009
- Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety. Pharmacol Ther. 2022;229():
- Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis. Gut. 2022;71(12): 2414-2429
- Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion. Arthritis Rheumatol. 2022;74(1): 33-37
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS). Ann Rheum Dis. 2022;81(3): 359-369